Nucleus pulposus stem cells (NPSCs) senescence plays a critical role in the progression of intervertebral disc degeneration (IDD). Stem cell-derived extracellular vesicles (EV) alleviate cellular senescence. Whereas, the underlying mechanism ...
Read More »EXOSOME NEWS
Assessing breast cancer molecular subtypes using extracellular vesicles’ mRNA
Extracellular vesicles (EVs) carry RNA cargo that is believed to be associated with the cell-of-origin and thus have the potential to serve as a minimally...
Read More »PhD research scholarship available: Exosomes as biomarkers for liver disease
The project aims to identify exosome-related biomarkers for liver diseases, with a view towards developing a test or potential drug targets for liver diseases. Exosomes will be isolated from blood and saliva samples from liver disease patients...
Read More »Stem cell scientists call for regulation of ‘treatment’ fads
Scientists are calling for tighter regulation of stem cell treatments, after finding hundreds of clinics worldwide offering unproven ‘therapies’ for conditions as varied as hair loss and Parkinson’s...
Read More »Single-cell RNA-sequencing data reveals the genetic source of extracellular vesicles in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is invasive cancer and the complex mechanisms underlying carcinogenesis remain unclear. Extracellular vesicles (EVs), secreted by most cell types, serve...
Read More »Genetically engineered artificial exosome-constructed hydrogel for ovarian cancer therapy
Owing to the insidious onset of ovarian cancer, most patients are in the advanced stage with extensive peritoneal metastasis when they are diagnosed...
Read More »ExoCoBio granted first plant stem cell-derived exosome patent in the US
ExoCoBio announced that it has obtained a patent (US Application No: 17/141,693) from the US Patent and Trademark Office for a cosmetic composition...
Read More »Isolation of bovine milk exosome using electrophoretic oscillation assisted tangential flow filtration
Tangent flow-driven ultrafiltration (TF-UF) is an efficient isolation process of milk exosomes without morphological deformation. However, the TF-UF approach with micro-ultrafiltration SiNx membrane filters suffers from the clogging and fouling of ...
Read More »NurExone granted US patent for technology and drug composition of Exo-PTEN, designed for treating acute spinal cord injuries
NurExone Biologic Inc, a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal cord injuries, announces that the Company has received an issue...
Read More »New liquid biopsy method offers potential for noninvasive Parkinson’s disease testing
EVtrap technology identifies proteins from brain cells in urine samples. A team led by researchers at Purdue University and Purdue spinoff company Tymora Analytical Operations has developed a technique that may reveal signs of Parkinson’s...
Read More »Jobs
-
PhD position available – development of milk extracellular vesicles for therapeutic applications
We aim to test several hypothesises to further progress cow milk EVs application as a treatment for human digestive tract diseases and anomalies...
Read More » -
PhD research scholarship available: Exosomes as biomarkers for liver disease
-
Post-doc position available – extracellular vesicles biology
-
PhD project available – investigating the structure of extracellular vesicles and budded virus in baculovirus replication
-
Post-doc position available – microbiology and immunology
Industry News
-
Creative Biolabs Catches Wind of Stem Cell-Derived Exosome Therapeutics in Stroke
Considering a recently featured article by NIH introducing the therapeutic effects of NSC-derived exosomes in cerebral ischemia, Creative Biolabs updates its service portfolio related to stem cell-derived exosomes. Stroke often ...
Read More » -
Evox Therapeutics granted key US exosome purification patent
-
ExoCoBio granted first plant stem cell-derived exosome patent in the US
-
NurExone granted US patent for technology and drug composition of Exo-PTEN, designed for treating acute spinal cord injuries
-
Mursla Bio to showcase its novel tissue-specific extracellular vesicle isolation technology at ISEV2023